Role of adipocytokines in predicting the development of diabetes and its late complications

被引:47
作者
Gulcelik, Nese Ersoz [1 ]
Usman, Aydan [1 ]
Gurlek, Alper [1 ]
机构
[1] Hacettepe Univ, Sch Med, Dept Endocrinol & Metab, Ankara, Turkey
关键词
Adipocytokines; Diabetes mellitus; Adiponectin; Leptin; Visfatin; Vaspin; Complications; PLASMA VISFATIN CONCENTRATIONS; MOLECULAR-WEIGHT ADIPONECTIN; SERINE-PROTEASE INHIBITOR; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; SERUM ADIPONECTIN; ADIPOSE-TISSUE; MICROVASCULAR COMPLICATIONS; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION;
D O I
10.1007/s12020-009-9234-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is an important health problem since the incidence of diabetes is continuously increasing. Early diagnosis is important as type 2 diabetes begins long before we diagnose it, leading to a complicated course of the disease. In order to prevent delay in the diagnosis of type 2 diabetes, novel predictors and pathways for type 2 diabetes are mounting. Diabetic complications are common cause of morbidity and mortality among subjects with diabetes. In the pathogenesis of diabetic complications some factors other than chronic hyperglycemia may be involved. Adipocytokines play important roles in the pathogenesis of diabetes mellitus, insulin resistance, and associated metabolic conditions such as hypertension and dyslipidemia. The investigations on the role of adipocytokines in developing diabetes and its complications have been made. In this review, we discussed the implications of adipocytokines in predicting diabetes and diabetic complications, with particular attention on the roles of adiponectin, leptin, visfatin, and vaspin.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 93 条
[81]   Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase [J].
Yamauchi, T ;
Kamon, J ;
Minokoshi, Y ;
Ito, Y ;
Waki, H ;
Uchida, S ;
Yamashita, S ;
Noda, M ;
Kita, S ;
Ueki, K ;
Eto, K ;
Akanuma, Y ;
Froguel, P ;
Foufelle, F ;
Ferre, P ;
Carling, D ;
Kimura, S ;
Nagai, R ;
Kahn, BB ;
Kadowaki, T .
NATURE MEDICINE, 2002, 8 (11) :1288-1295
[82]   The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity [J].
Yamauchi, T ;
Kamon, J ;
Waki, H ;
Terauchi, Y ;
Kubota, N ;
Hara, K ;
Mori, Y ;
Ide, T ;
Murakami, K ;
Tsuboyama-Kasaoka, N ;
Ezaki, O ;
Akanuma, Y ;
Gavrilova, O ;
Vinson, C ;
Reitman, ML ;
Kagechika, H ;
Shudo, K ;
Yoda, M ;
Nakano, Y ;
Tobe, K ;
Nagai, R ;
Kimura, S ;
Tomita, M ;
Froguel, P ;
Kadowaki, T .
NATURE MEDICINE, 2001, 7 (08) :941-946
[83]  
Yamauchi Toshimasa, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P243, DOI 10.2174/1568008033340090
[84]   Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin [J].
Yang, WS ;
Lee, WJ ;
Funahashi, T ;
Tanaka, S ;
Matsuzawa, Y ;
Chao, CL ;
Chen, CL ;
Tai, TY ;
Chuang, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3815-3819
[85]  
Yenicesu M, 2005, CLIN NEPHROL, V64, P12
[86]   Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin [J].
Yilmaz, Mahmut Ilker ;
Saglam, Mutlu ;
Qureshi, Abdul Rashid ;
Carrero, Juan Jesus ;
Caglar, Kayser ;
Eyileten, Tayfun ;
Sonmez, Alper ;
Cakir, Erdinc ;
Oguz, Yusuf ;
Vural, Abdulgaffar ;
Yenicesu, Mujdat ;
Stenvinkel, Peter ;
Lindholm, Bengt ;
Axelsson, Jonas .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (05) :1621-1627
[87]   Adiponectin may play a part in the pathogenesis of diabetic retinopathy [J].
Yilmaz, MI ;
Sonmez, A ;
Acikel, C ;
Celik, T ;
Bingol, N ;
Pinar, M ;
Bayraktar, Z ;
Ozata, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (01) :135-140
[88]   Serum vaspin concentrations in human obesity and type 2 diabetes [J].
You, Byung-Soo ;
Kloeting, Nora ;
Kratzsch, Juergen ;
Lee, Namseok ;
Park, Ji Woo ;
Song, Eun-Sun ;
Ruschke, Karen ;
Oberbach, Andreas ;
Fasshauer, Mathias ;
Stumvoll, Michael ;
Blueher, Matthias .
DIABETES, 2008, 57 (02) :372-377
[89]   A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes [J].
Zhang, Yuan-Yuan ;
Gottardo, Lucia ;
Thompson, Ryan ;
Powers, Christine ;
Nolan, David ;
Duffy, Jill ;
Marescotti, Maria Cristina ;
Avogaro, Angelo ;
Doria, Alessandro .
OBESITY, 2006, 14 (12) :2119-2126
[90]   POSITIONAL CLONING OF THE MOUSE OBESE GENE AND ITS HUMAN HOMOLOG [J].
ZHANG, YY ;
PROENCA, R ;
MAFFEI, M ;
BARONE, M ;
LEOPOLD, L ;
FRIEDMAN, JM .
NATURE, 1994, 372 (6505) :425-432